Importantly, in adult TBI, molecules such as glial fibrillary acid protein (GFAP) and ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) have recently been approved by the Food and Drug Administration (FDA) as blood biomarkers in mTBI [42]. The gene discussed is GFAP; the disease is concussion.